Testosterone Topical Solution (InvaGen) – Defective Container (2019)
Class III: A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences
Class III recall indicates unlikely adverse health consequences.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 mL of solution Total contents: 110 mL to deliver 90 mL, Manufactured by: Cipla Ltd, Verna Goa, India Manufactured for: Cipla USA, Inc., Sunrise, FL 33323 NDC 69097-363-44
Brand
InvaGen Pharmaceuticals, Inc.
Lot Codes / Batch Numbers
Lot GH80480 and GH80481, exp 3/2020
Products Sold
Lot GH80480 and GH80481, exp 3/2020
InvaGen Pharmaceuticals, Inc. is recalling Testosterone Topical Solution 30mg of testosterone per pump actuation * each actuation delivers 1.5 due to Defective Container; actuator may improperly function and affect dose delivery.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Defective Container; actuator may improperly function and affect dose delivery.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026